Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, October 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 30,134 followers.

I never really learned about circular RNA...it seems like a really emerging and cool field...in this paper they say that it reprograms the #immunesystem to allow the cancer to grow...primarily by modulating macrophages https://t.co/9C9qTPKZ2C

02 Nov 2022

Reply Repost Favourite

RT @JournalofExper1: New! 📍 Exosomal circZNF451 restrains anti-PD1 treatment in #lungadenocarcinoma via polarizing macrophages by complexi…

14 Oct 2022

Reply Repost Favourite

Exosomal circZNF451 restrains anti-PD1 treatment in #lungadenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1 Full study 👇 https://t.co/UiWTMWb5UV

12 Oct 2022

Reply Repost Favourite

RT @JournalofExper1: New! 📍 Exosomal circZNF451 restrains anti-PD1 treatment in #lungadenocarcinoma via polarizing macrophages by complexi…

12 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.